MARKET ACCESS
Leading the Conversation iLorim Ipsum
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Insights Gathering & Strategy Development
Insights Gathering & Strategy Development
Define where access is won or lost. Integrate payer, provider, and patient insight into a strategy grounded in real decision drivers, market dynamics, and business objectives.
Audience &
Segmentation
Understand who matters most, what drives behavior, and where messaging can create the greatest lift across priority segments.
Messaging &
Positioning
Build sharper narratives rooted in clinical value, unmet need, and competitive differentiation so your brand lands with clarity.
Channel &
Activation Planning
Match strategy to the right channels, content, and timing so execution feels connected, efficient, and measurable.
Optimization &
Performance
Use performance signals to refine direction, strengthen investment decisions, and improve outcomes over time.
What It Takes to
Win in Access
Align Strategy to Real-World Decisions
We align stakeholders with deep market insights to ensure your strategy, content, and execution are targeted, measurable, and effective.
Secure Coverage Through Proven Value
We demonstrate clinical and economic impact, providing the rigorous scrutiny payers require to justify broad coverage and reimbursement.
Enable Seamless Care Delivery
We help systems integrate new therapies into existing workflows, reducing implementation barriers and improving the provider experience.
Remove Barriers to Therapy Persistence
We identify and solve the financial and logistical challenges that hinder treatment, improving real-world initiation and long-term continuity.
Empower Field Teams Across the Account
We enable teams to navigate complex decision-making ecosystems, improving coordination and engagement across all key account stakeholders.
20% Increase in Physician Discussions
Aligned clinical value across stakeholders to support access, coverage decisions, and broader adoption.
Our Perspectives on Market Access
The Modern Medical Affairs Impact Playbook
The Modern Medical Affairs Impact Playbook
Strategic KOL Engagement in Medical Affairs: A Playbook for Maximizing Impact
Strategic KOL Engagement in Medical Affairs: A Playbook for Maximizing Impact
The Use of AI in Imaging for Alzheimer’s Disease
The Use of AI in Imaging for Alzheimer’s Disease
Frequently Asked Questions
What does a pharmaceutical advertising agency do?
A pharmaceutical advertising agency translates clinical and scientific value into clear, compelling communication that supports awareness, understanding, and engagement across stakeholders. This includes HCP advertising strategy, disease awareness campaigns, brand positioning, congress activation, HCP engagement, and omnichannel engagement.
At BGBx, we operate as a commercial solutions partner for the life sciences industry. Using our proprietary Breakthrough Platform, powered by 3D Science, we validate strategy at every stage, ensuring campaigns are grounded in evidence, aligned to market realities, and positioned to deliver measurable commercial impact.
What is pharmaceutical market access strategy?
Pharmaceutical market access strategy is the process of aligning clinical evidence, economic value, and stakeholder engagement to support a therapy in securing coverage, integrating into care pathways, and performing in real-world settings.
At BGBx, we design market access strategy as a coordinated system that connects value, stakeholders, and execution from pre-launch through lifecycle management.
What makes BGBx’s market access approach different?
At BGBx, our market access approach is different because we integrate strategy and execution into a single, validated system.
Using our proprietary Breakthrough Platform, powered by 3D Science, we validate strategy at every stage, grounding access plans in real-world evidence and testing them before scaling.
How does BGBx support therapies in securing payer coverage?
Supporting payer coverage requires aligning clinical and economic value to how payers evaluate therapies in real-world conditions.
At BGBx, we develop evidence-based value narratives and validate them with payer-relevant stakeholders, testing assumptions against real-world decision criteria to strengthen reimbursement and formulary positioning.
How does BGBx improve patient access and treatment continuity?
At BGBx, we improve patient access and treatment continuity by identifying and addressing financial, logistical, and process barriers that can prevent therapy initiation and persistence.
We design connected solutions that support patients, providers, and brands across the treatment journey to improve access, adherence, and long-term outcomes.
Leading the Conversation iLorim Ipsum
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
